Your session is about to expire
← Back to Search
Panbio™ for COVID-19 and Flu
Study Summary
This trial tests devices to detect COVID-19, flu A, and flu B in nasal swabs. It helps assess device safety & performance to support CE conformity.
- COVID-19
- Coronavirus
- Flu
- Flu Type B
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Group 1: Nasal sampling/Testing (Self-Test) + Nasopharyngeal sampling/Testing (Professional Use)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many people have signed up for participation in this clinical research?
"Affirmative. Clinicaltrials.gov's data reveals that recruitment for this study is ongoing and commenced on March 1st 2023. The most recent update was dated February 3rd 2023, with the aim of finding 1531 participants from just one site."
Are there any open slots for volunteers in this trial?
"Affirmative. The clinical trial data hosted on clinicaltrials.gov confirms that this experiment is currently recruiting participants, with the original post date of March 1st 2023 and the most recently updated information being from February 3rd 2023. 1531 people are required to be enrolled at just one medical centre."
Share this study with friends
Copy Link
Messenger